Company Analysis

Halozyme Therapeutics, Inc. (HALO)

Nasdaq: HALO · Biological Products, (No Diagnostic Substances) · San Diego, CA · filing with the SEC since 2001
Grade6.8
◀ Past 7.9● Present 7.3▶ Future 5.2

Who runs Halozyme Therapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Torley Helen
PRESIDENT AND CEO. First filing Jan 2014, latest Oct 8, 2026, 41 filings in all.
Officers reporting now
6
of 14 people with a filing in the last fifteen months
Directors reporting now
8
30 people on the record since 2006
Officerssales are open-market, Oct 8, 2025 to Oct 8, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Torley HelenPRESIDENT AND CEOJan 2014Oct 8, 202685 · $42.1M
Ramsay David AEVP, PRESIDENT, DRUG DELIVERYFeb 2007Jul 2, 2026none
Snellgrove DarrenSVP, Chief Financial OfficerJun 2026Jul 2, 2026none
Snyder Mark HowardSVP, CHIEF LEGAL OFFICERJan 2022Jun 15, 2026none
Caudill CortneySVP, CHIEF OPERATING OFFICEROct 2025Mar 10, 20264 · $2.2M
Labrosse NicoleSVP, CHIEF FINANCIAL OFFICERFeb 2022Feb 24, 2026none
Directorssales are open-market, Oct 8, 2025 to Oct 8, 2026
NameRoleFirst filingLatest filingSales, 12 months
Connaughton BernadettedirectorSep 2018Oct 8, 20268 · $800,000
Daly James MdirectorMar 2016Oct 2, 2026none
Posard Matthew L.directorMar 2013Oct 2, 20268 · $2.6M
Appelhans DannielledirectorAug 2026Sep 2, 2026none
Krishnan MaheshdirectorApr 2024Jun 30, 20261 · $500,000
Duncan Barbara GayledirectorFeb 2023May 7, 2026none
Henderson Jeffrey WilliamdirectorAug 2015May 7, 2026none
Lang James PauldirectorJan 2026May 7, 2026none
Earlier names on the record16, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton HALO · research, not advice